Malaysia Sees Shift Beyond Chemotherapy in Blood Cancer Treatment Advances

Published on: April 2026

It is witnessing a major shift in blood cancer treatment, moving beyond traditional chemotherapy toward advanced approaches such as targeted therapy and immunotherapy.

These innovations are improving survival outcomes and offering more precise, personalized care for patients with conditions like leukemia, lymphoma, and multiple myeloma.

Shift Toward Targeted and Personalised Therapies

Healthcare providers are increasingly adopting targeted cancer therapies that focus on specific molecular pathways involved in tumor growth.

Unlike chemotherapy, these treatments:

• Target cancer-specific mutations
• Reduce damage to healthy cells
• Improve treatment precision

This aligns with the global trend toward precision medicine in oncology.

Rise of Immunotherapy and CAR-T Cell Therapy

Immunotherapy is emerging as a key treatment option, helping the immune system identify and destroy cancer cells.

One of the most advanced approaches is CAR-T cell therapy, which involves modifying a patient’s immune cells to target cancer more effectively.

These therapies are particularly beneficial for:

• Relapsed or resistant blood cancers
• Patients not responding to chemotherapy
• Complex hematological conditions

Challenges in Access and Affordability

Despite advancements, access to new treatments remains limited due to high costs and infrastructure requirements.

Key challenges include the following:

• Expensive treatment costs
• Limited specialised facilities
• Need for advanced clinical expertise

Addressing these barriers is essential to ensure wider adoption of innovative therapies.

Role of Hospitals and Specialist Care

Hospitals and cancer centers are expanding oncology and hematology services to support advanced treatments.

Multidisciplinary teams play a crucial role in:

• Treatment planning
• Patient monitoring
• Managing complex therapies

Impact on Cancer Care and Public Health

The shift beyond chemotherapy reflects a broader transformation in cancer care, focusing on precision medicine and long-term disease management.

Benefits for patients include:

• Improved survival rates
• Reduced side effects
• More personalised treatment options

However, continued investment in healthcare infrastructure, policy support, and awareness is necessary to ensure equitable access.

As innovation continues, it is aligning its healthcare system with global advancements in oncology, balancing cutting-edge treatments with accessibility for patients.